|
Basem Al-Shayeb
|
|
Basem Al-Shayeb is an Egyptian American microbiologist who is a co-founder and the founding chief technology officer of Amber Bio He received his PhD in microbial biology as a National Science Foundation Fellow at the University of California, Berkeley and Innovative Genomics Institute, where he conducted his dissertation work in the lab of Jennifer Doudna, and in the Earth and Planetary Science Department advised by Jillian Banfield. According to ORCID records, he is an active peer reviewer for Nature Portfolio research for several journals including Nature, Nature Communications, and '. During his time at UC Berkeley, he led or was co-first author on publications describing the discovery of the largest known bacteriophages in Nature, the smallest CRISPR-Cas genome editing systems in Science and Cell and a new form of extrachromosomal DNA elements, termed "Borgs," found in methane-oxidizing archaea (Methanoperedens spp.) in Nature. Some of the aforementioned CRISPR-Cas enzymes are licensed by Mammoth Biosciences for diagnostic and therapeutic development. He was listed in Forbes 30 Under 30 and Arab America's 30 Under 30 in 2021, and Forbes All-Star Alumni in 2024 for his scientific discoveries and contributions. 
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
